Literature DB >> 21848483

Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia.

Giovanna Ogge1, Tinnakorn Chaiworapongsa, Roberto Romero, Youssef Hussein, Juan Pedro Kusanovic, Lami Yeo, Chong Jai Kim, Sonia S Hassan.   

Abstract

OBJECTIVE: Preeclampsia (PE) has been classified into early- and late-onset disease. These two phenotypic variants of PE have been proposed to have a different pathophysiology. However, the gestational age cut-off to define "early" vs. "late" PE has varied among studies. The objective of this investigation was to determine the prevalence of lesions consistent with maternal underperfusion of the placenta in patients with PE as a function of gestational age. STUDY
DESIGN: A nested case-control study of 8307 singleton pregnant women who deliver after 20 weeks of gestation was constructed based on a cohort. Cases were defined as those with PE (n=910); controls were pregnant women who did not have a hypertensive disorder in pregnancy (n=7397). The frequency of maternal underperfusion of the placenta (according to the criteria of the Society for Pediatric Pathology) was compared between the two groups. Logistic regression was used for analysis. Estimated relative risks (RRs) were calculated from odds ratios.
RESULTS: 1) The prevalence of lesions consistent with maternal underperfusion was higher in patients with PE than in the control group [43.3% vs. 15.9%, unadjusted odds ratio 4.0 (95% CI 3.5-4.7); P<0.001]; 2) the estimated RR of maternal underperfusion lesions in PE was higher than in the control group [RR=2.8 (95% CI 2.5-3.0)]; 3) the lower the gestational age at delivery, the higher the RR for these lesions; 4) early-onset PE, regardless of the gestational age used to define it (<32, 33, 34, 35 or 37 weeks) had a significantly higher frequency of placental lesions consistent with maternal underperfusion than late-onset PE (P<0.001 for all).
CONCLUSIONS: 1) The earlier the gestational age of preeclampsia at delivery, the higher the frequency of placental lesions consistent with maternal underperfusion; 2) our data suggest that demonstrable placental involvement as determined by pathologic examination differs in early- and late-onset preeclampsia; and 3) this phenomenon appears to be a continuum, and we could not identify a clear and unambiguous gestational age at which lesions consistent with underperfusion would not be present.

Entities:  

Mesh:

Year:  2011        PMID: 21848483      PMCID: PMC3213694          DOI: 10.1515/jpm.2011.098

Source DB:  PubMed          Journal:  J Perinat Med        ISSN: 0300-5577            Impact factor:   1.901


  157 in total

1.  Are early and late preeclampsia distinct subclasses of the disease--what does the placenta reveal?

Authors:  J L van der Merwe; D R Hall; C Wright; P Schubert; D Grové
Journal:  Hypertens Pregnancy       Date:  2010       Impact factor: 2.108

2.  Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction.

Authors:  D Schlembach; W Wallner; R Sengenberger; E Stiegler; M Mörtl; M W Beckmann; U Lang
Journal:  Ultrasound Obstet Gynecol       Date:  2007-04       Impact factor: 7.299

3.  Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature.

Authors:  Thomas Walther; Gerd Wallukat; Alexander Jank; Sabine Bartel; Heinz-Peter Schultheiss; Renaldo Faber; Holger Stepan
Journal:  Hypertension       Date:  2005-10-31       Impact factor: 10.190

Review 4.  First trimester screening for preeclampsia.

Authors:  Aris T Papageorghiou; Stuart Campbell
Journal:  Curr Opin Obstet Gynecol       Date:  2006-12       Impact factor: 1.927

Review 5.  Supplementation with vitamins C and E during pregnancy for the prevention of preeclampsia and other adverse maternal and perinatal outcomes: a systematic review and metaanalysis.

Authors:  Agustín Conde-Agudelo; Roberto Romero; Juan Pedro Kusanovic; Sonia S Hassan
Journal:  Am J Obstet Gynecol       Date:  2011-05-06       Impact factor: 8.661

6.  Different profiles of circulating angiogenic factors and adipocytokines between early- and late-onset pre-eclampsia.

Authors:  H Masuyama; T Segawa; Y Sumida; A Masumoto; S Inoue; Y Akahori; Y Hiramatsu
Journal:  BJOG       Date:  2009-12-10       Impact factor: 6.531

7.  Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction.

Authors:  Fàtima Crispi; Carmen Domínguez; Elisa Llurba; Pilar Martín-Gallán; Luís Cabero; Eduard Gratacós
Journal:  Am J Obstet Gynecol       Date:  2006-03-20       Impact factor: 8.661

8.  Hypertensive disorders in pregnancy: screening by uterine artery Doppler at 11-13 weeks.

Authors:  L C Y Poon; I Staboulidou; N Maiz; W Plasencia; K H Nicolaides
Journal:  Ultrasound Obstet Gynecol       Date:  2009-08       Impact factor: 7.299

9.  Uterine artery Doppler velocimetry in relation to trophoblast migration into the myometrium of the placental bed.

Authors:  S Lin; I Shimizu; N Suehara; M Nakayama; T Aono
Journal:  Obstet Gynecol       Date:  1995-05       Impact factor: 7.661

10.  Systemic hemodynamic and regional blood flow changes in response to chronic reductions in uterine perfusion pressure in pregnant rats.

Authors:  M M Sholook; J S Gilbert; M H Sedeek; M Huang; R L Hester; J P Granger
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-07-20       Impact factor: 4.733

View more
  63 in total

1.  Changes of placental syndecan-1 expression in preeclampsia and HELLP syndrome.

Authors:  Szilvia Szabo; Yi Xu; Roberto Romero; Tibor Fule; Katalin Karaszi; Gaurav Bhatti; Tibor Varkonyi; Ildiko Varkonyi; Tibor Krenacs; Zhong Dong; Adi L Tarca; Tinnakorn Chaiworapongsa; Sonia S Hassan; Zoltan Papp; Ilona Kovalszky; Nandor Gabor Than
Journal:  Virchows Arch       Date:  2013-06-27       Impact factor: 4.064

2.  Prenatal diagnosis of a placental infarction hematoma associated with fetal growth restriction, preeclampsia and fetal death: clinicopathological correlation.

Authors:  Alma Aurioles-Garibay; Edgar Hernandez-Andrade; Roberto Romero; Faisal Qureshi; Hyunyoung Ahn; Suzanne M Jacques; Maynor Garcia; Lami Yeo; Sonia S Hassan
Journal:  Fetal Diagn Ther       Date:  2014-05-17       Impact factor: 2.587

3.  Evolutionary origins of the placental expression of chromosome 19 cluster galectins and their complex dysregulation in preeclampsia.

Authors:  N G Than; R Romero; Y Xu; O Erez; Z Xu; G Bhatti; R Leavitt; T H Chung; H El-Azzamy; C LaJeunesse; B Wang; A Balogh; G Szalai; S Land; Z Dong; S S Hassan; T Chaiworapongsa; M Krispin; C J Kim; A L Tarca; Z Papp; H Bohn
Journal:  Placenta       Date:  2014-08-26       Impact factor: 3.481

4.  The anti-aging factor α-klotho during human pregnancy and its expression in pregnancies complicated by small-for-gestational-age neonates and/or preeclampsia.

Authors:  Jezid Miranda; Roberto Romero; Steven J Korzeniewski; Alyse G Schwartz; Piya Chaemsaithong; Tamara Stampalija; Lami Yeo; Zhong Dong; Sonia S Hassan; George P Chrousos; Philip Gold; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2013-08-19

5.  Integrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia.

Authors:  Nandor Gabor Than; Roberto Romero; Adi Laurentiu Tarca; Katalin Adrienna Kekesi; Yi Xu; Zhonghui Xu; Kata Juhasz; Gaurav Bhatti; Ron Joshua Leavitt; Zsolt Gelencser; Janos Palhalmi; Tzu Hung Chung; Balazs Andras Gyorffy; Laszlo Orosz; Amanda Demeter; Anett Szecsi; Eva Hunyadi-Gulyas; Zsuzsanna Darula; Attila Simor; Katalin Eder; Szilvia Szabo; Vanessa Topping; Haidy El-Azzamy; Christopher LaJeunesse; Andrea Balogh; Gabor Szalai; Susan Land; Olga Torok; Zhong Dong; Ilona Kovalszky; Andras Falus; Hamutal Meiri; Sorin Draghici; Sonia S Hassan; Tinnakorn Chaiworapongsa; Manuel Krispin; Martin Knöfler; Offer Erez; Graham J Burton; Chong Jai Kim; Gabor Juhasz; Zoltan Papp
Journal:  Front Immunol       Date:  2018-08-08       Impact factor: 7.561

6.  Activation of villous trophoblastic p38 and ERK1/2 signaling pathways in preterm preeclampsia and HELLP syndrome.

Authors:  Szilvia Szabo; Meera Mody; Roberto Romero; Yi Xu; Katalin Karaszi; Noemi Mihalik; Zhonghui Xu; Gaurav Bhatti; Tibor Fule; Petronella Hupuczi; Tibor Krenacs; Janos Rigo; Adi L Tarca; Sonia S Hassan; Tinnakorn Chaiworapongsa; Ilona Kovalszky; Zoltan Papp; Nandor Gabor Than
Journal:  Pathol Oncol Res       Date:  2015-01-13       Impact factor: 3.201

7.  Risk of Preeclampsia in Pregnancies After Assisted Reproductive Technology and Ovarian Stimulation.

Authors:  Angela S Martin; Michael Monsour; Jennifer F Kawwass; Sheree L Boulet; Dmitry M Kissin; Denise J Jamieson
Journal:  Matern Child Health J       Date:  2016-10

8.  Stillbirth, hypertensive disorders of pregnancy, and placental pathology.

Authors:  Karen J Gibbins; Robert M Silver; Halit Pinar; Uma M Reddy; Corette B Parker; Vanessa Thorsten; Marian Willinger; Donald J Dudley; Radek Bukowski; George R Saade; Matthew A Koch; Deborah Conway; Carol J Hogue; Barbara J Stoll; Robert L Goldenberg
Journal:  Placenta       Date:  2016-05-07       Impact factor: 3.481

9.  The profiles of soluble adhesion molecules in the "great obstetrical syndromes".

Authors:  Nikolina Docheva; Roberto Romero; Piya Chaemsaithong; Adi L Tarca; Gaurav Bhatti; Percy Pacora; Bogdan Panaitescu; Noppadol Chaiyasit; Tinnakorn Chaiworapongsa; Eli Maymon; Sonia S Hassan; Offer Erez
Journal:  J Matern Fetal Neonatal Med       Date:  2018-02-01

10.  Maternal plasma soluble TRAIL is decreased in preeclampsia.

Authors:  Piya Chaemsaithong; Tinnakorn Chaiworapongsa; Roberto Romero; Steven J Korzeniewski; Tamara Stampalija; Nandor Gabor Than; Zhong Dong; Jezid Miranda; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2013-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.